Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: elective admission for carotid stents major surgical or invasive procedure: carotid stent history of present illness: 64 yo male with hx of htn, hyperlipidemia, dm, copd, cad s/p cabg, pvd, hx of cva who is being admitted for elective carotid stents. he had an episode of cva in ' with left side weakness with prompt resolution of sx. at that time, the work up showed mild right carotid disease but no left carotid dz. stroke at that time was thought to be likely due to cardioembolic or archembolic source. no coumadin started. pt has been experiencing worsening le cluadication for the past 3-4 years. follow up carotid and arterial studies showed bilateral 80-99% ica stenosis, signficiant l sfa dz, mild r tibial dz, abi on the r 0.97, l 0.66. pt denies any headache, visual changes, focal weakness, sensory changes, trouble swallowing, or slurred speech. he does have trouble with gait and balance but has been chronic. pt denies having syncope or seizure in the past. pt reports he has not had any anginal sx since cabg. past medical history: htn hyperlipidemia dm cad-s/p cabg in ': lima to lad, vein graft to pda, om and left posterolateral. ef 45% cva- with left sided weakness, promptoly resolved. chf: ef 45% pvd cri: cr 1.9 on recent lab left side deafness hx of infection to left orbital bone s/p sinus obliteration s/p left stapedectomy (stapedius removal after getting infected) copd obesity urinary urgency social history: pt lives with his wife and daughter. works for division of taxation. he is a former smoker, used to smoke 3 packs/day x 20 yrs but quit 25 yrs ago. pt denies alcohol or drugs. family history: strong hx of hyperlipidemia, hereditary. father died of mi at age 61 paternal grandfather died of mi in his 50's 2 of his brothers with cabg; one in his 50's and one in his 40's. physical exam: vs t 98.7 bp 146/56 hr 68 rr 18 o2sat 99% ra gen: obese man with right side hearing aid, sitting in chair in nad. heent: nc/at, +right side hearing air, scar on his left supra-orbital region. few macular rash on his cheek. op clear. cor: distant heart sounds, s1, s2, no murmurs appreciated. no jvd. no carotid bruits bilaterally. lungs: diffusely decreased bs; no crackles or wheezes abd: soft, ntnd, +bs ext: 1+ femoral pulses bilaterally, no bruits. 1+ dp bilaterally. warm ble neuro: alert & oriented x3, cn iii-xii intact except for left hearing. strengths major muscle groups. reflexes all 4 extremities. pt with unsteady gait. pertinent results: 10:22pm glucose-114* urea n-41* creat-1.4* sodium-139 potassium-4.0 chloride-103 total co2-28 anion gap-12 10:22pm calcium-9.2 phosphate-3.1 magnesium-2.2 cholest-124 10:22pm triglycer-218* hdl chol-29 chol/hdl-4.3 ldl(calc)-51 10:22pm wbc-9.5 rbc-4.17* hgb-12.2* hct-35.1* mcv-84 mch-29.2 mchc-34.7 rdw-13.2 10:22pm plt count-187 10:22pm pt-13.1 ptt-29.2 inr(pt)-1.1 carotid stenting 1. access was retrograde via the right cfa to the selective carotid arteries. 2. thoracic aorta: type i arch. 3. carotid/vertebral arteries: the rcca was normal. the had a 90% lesion with ipsilateral filling of the mca only. the lcca was normal. the had a 90% lesion and filled the mca, aca, and contralateral aca. 4. stenting of the was performed with a x 30 mm acculink. 5. the groin was closed with a perclose device. final diagnosis: 1. severe bilateral carotid disease. 2. stenting of the . 3. perclose of the groin. brief hospital course: 1)carotid stenting: the patient underwent carotid stenting on by dr. to the . since his recent outpatient lab showed cr of 1.9, he was admitted for pre-op hydration and mucomyst. during the procedure, he was given morphine in anticipation of pain associated with suturing the groin. after the morphine, he had some mild left sided weakness that was his weakness with is initial cva. he was given narcan and this completely resolved. he was transferred to the floor without hypotension. the sheath was pulled without incident and nis neuro exams were normal (with the exception of gait). 2)cad: pt s/p cabg and asymptomatic at this time. continued norvasc, toprol, lisinopril, plavix, , , pravachol, zetia 3)htn: continued spironolactone 25 mg qd, norvasc 10 mg qd, toprol 50 mg qd, lisinopril 40 mg qd, lasix 120 mg po bid, 160 mg . 4)hyperlipidemia: continued pravachol 80 mg qd, zetia 10 mg po qd 5)dm: continued humalog 75/25 units 60 units breakfast, 20 units lunch, 60 units dinner, and cover with riss qid. 6)chf: ef 45%, no signs of failure. 7)cri: cr 1.9 on recent outpt labs. will repeat labs. cri most likely chronic from dm and htn, and not arf. gave pre-hydration, mucomyst, peri-cath bicarb to protect the kidneys. 8)urinary urgency: pt takes detrol 4 mg . gave 2 mg since that is the recommended dosage. medications on admission: spironolactone 25 mg po qam norvasc 10 mg po qam toprol 50 mg po qam lisinopril 40 mg po qam detrol la 4 mg po bid plavix 75 mg qam lasix 120 mg po bid 160 mg po bid pravachol 80 mg qpm 325 mg po qd humalog 75/25 60 u w/breakfast, 20 u w/lunch, 60 u w/dinner nitroglycerin 0.2 mg prn zetia 10 mg po qd advair combivent discharge medications: 1. clopidogrel bisulfate 75 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*6* 2. furosemide 40 mg tablet sig: three (3) tablet po bid (2 times a day). 3. pravastatin sodium 20 mg tablet sig: four (4) tablet po hs (at bedtime). 4. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 5. nitroglycerin 0.3 mg tablet, sublingual sig: one (1) tablet, sublingual sublingual prn (as needed) as needed for chest pain. 6. combivent 103-18 mcg/actuation aerosol sig: inhalation twice a day. 7. advair diskus 100-50 mcg/dose disk with device sig: one (1) inhalation twice a day. 8. ezetimibe 10 mg tablet sig: one (1) tablet po daily (daily). 9. tolterodine tartrate 2 mg tablet sig: one (1) tablet po bid (2 times a day). 10. metoprolol succinate 50 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po daily (daily). 11. enoxaparin sodium 100 mg/ml syringe sig: one (1) subcutaneous q12h (every 12 hours): stop once inr >2.0. disp:*30 qs* refills:*2* 12. aldactone 25 mg tablet sig: one (1) tablet po once a day. 13. warfarin sodium 5 mg tablet sig: one (1) tablet po hs (at bedtime). disp:*30 tablet(s)* refills:*2* discharge disposition: home discharge diagnosis: carotid stenosis s/p right ica stent atrial fibrillation obstructive sleep apnea discharge condition: good discharge instructions: call dr. if you feel dizzy at all. do not take your amlodipine, valsartan, lisinopril until you hear from dr on monday. please follow up with your pcp and have your inr checked. once you become therapeutic with your coumadin, you may stop taking lovenox. never stop your plavix or asprin. followup instructions: please follow up with your pcp, on monday at 9:15, at which point you'll have your inr checked and coumadin dose changed accordingly. provider: study where: cc clinical center radiology phone: date/time: 10:00 provider: , m.d. where: cardiac services phone: date/time: 1:00 procedure: percutaneous angioplasty of extracranial vessel(s) percutaneous insertion of carotid artery stent(s) diagnoses: nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere congestive heart failure, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft aortocoronary bypass status unspecified disorder of kidney and ureter occlusion and stenosis of multiple and bilateral precerebral arteries without mention of cerebral infarction diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled 

Answer: The patient is high likely exposed to